Trial Profile
Comparative Effect of Valsartan and Ramipril on Atrial Fibrillation Recurrence in Hypertensive Patients with Diabetes Mellitus and Recurrent Lone Atrial Fibrillation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Sep 2015
Price :
$35
*
At a glance
- Drugs Ramipril (Primary) ; Valsartan (Primary)
- Indications Atrial fibrillation; Essential hypertension
- Focus Therapeutic Use
- 02 Sep 2015 New trial record